Notice of third-party allocation paid-in capital increase
2020.08.14
|
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Notice of third-party allocation paid-in capital increase
Hello, shareholder, I wish you good health
and good luck in your family.
There has been a great deal of development
outwardly, and it has been possible with the support and support of the
shareholders, and I would like to express my gratitude to the shareholders. As
the Board of Directors of 2020. 07. 31. has decided to issue new shares for the
purpose of raising operating funds as follows, the Company shall notify the
Stockholder in accordance with Article 418(4) of the Commercial Act.
1. Type and number of new shares:
registered common stock 411,241 shares
2. Issued value of new shares: 14,590 won
per share (extra 500 won in face value)
3. How to issue new shares: Third party
allocation method (according to Article 418 (2) of the Commercial Act and
Article 10-2-5 of the articles of association)
4. Purpose of Financing: Achieving
Management Purpose and Rapid Financing [Finance of Operational Funds]
5. Total issuance of new shares:
6,000,006,190 won
6. Subject to the issuance of new shares
7. Date of lead entry: 2020.08.31
8. Other matters
A) Other details on the issue of new shares
are delegated to the CEO.
B) This paid-in capital increase schedule
may be changed according to the adjustment process of the relevant agencies.
As mentioned above, we are notifying you of
the paid-in capital increase for third-party assignment. If you have any
questions, please contact us by August 28, 2020.
(031-214-9401, hepark@microbes.bio)
August 14th, 2020
HEM INC.
|